Manforce Staylong Tablet

Manforce Staylong Tablet is mixed with two drugs used to treat premature ejaculation in adult men. Boosts blood flow to the penis to help men have an erection. Manforce Staylong Tablet you can use only when prescribed by a doctor. Manforce Staylong Tablet is a phosphodiesterase type 5 inhibitor . It treats relax and dilates the body’s blood vessels. It assists increase blood flow in specific parts of the body. This medicine you can use to treat erectile dysfunction within men. It treats pulmonary arterial hypertension (PAH) and, over time, develops blank exercise capacity in both men and women. Your doctor can take it by mouth or inject it into the body.

Unwanted 21 Contraceptive Pills

Masolin Breast Massage Oil for women

Japani F Capsules for Female Sex Power

Penegra 100 Tablet Boosts sexual Stamina

Manforce Staylong Tablet helps rest the muscles around the blood vessels’ walls, increasing blood movement to specific areas of your body. Manforce Staylong Tablet also uses to treat erectile dysfunction in men. The reason could be impotence or the incapacity to maintain or get an erection.
There are certain things to be aware of when you are taking Manforce Staylong Tablet. First of all, avoid drinking alcohol as there may be possible side effects. Secondly, grapefruit products can react with Manforce Staylong Tablet and cause side effects. Therefore, you should avoid consuming grapefruit products. Also, be sure not to use any other medications related to the treatment of impotence and this medication. If you do, check with your doctor first.

Uses of Manforce Staylong Tablet
Premature ejaculation

A common side effect of Manforce Staylong Tablet
Most side effects do not require medical attention and disappear as your body adjusts to the medication. Consult your doctor if they persist or if they worry you

Nausea
Vomiting
Indigestion
Dryness in mouth
Headache
Flushing (sense of warmth in the face, ears, neck, and trunk)
Dizziness

When not to use Manforce Staylong Tablet?

Allergy
This medicine is not recommended for use in patients with a known allergy to sildenafil or dapoxetine or any other inactive ingredients present along with the formulation.

Heart failure
Manforce Staylong Tablet is not recommended for use in patients with a history of heart failure due to the increased risk of worsening the patient’s condition.

Heart rhythm disorders
This medicine is not recommended for use in patients with abnormalities of the heart rhythm due to the increased risk of worsening the patient’s condition.

Bipolar disorder
This medicine is not recommended for use in patients with a history of mania or severe depression (bipolar disorder) due to the increased risk of worsening the patient’s condition.

Loss of consciousness
Manforce Staylong Tablet is not recommended for use in patients having syncope characterized by frequent loss of consciousness and muscle strength due to the increased risk of worsening of the symptoms.

Kidney Disease
This medicine is not recommended for use in patients with kidney diseases due to the increased risk of worsening adverse effects.

Liver disease
This medicine is not recommended for use in patients with liver diseases due to the increased risk of worsening adverse effects.

Thioridazine
Manforce Staylong Tablet is not recommended for use if you are taking thioridazine. This medicine should not take within 14 days of discontinuing treatment with thioridazine. Similarly, thioridazine can be made seven days after stopping the uptake of this medicine.
Selective serotonin reuptake inhibitors (SSRIs)

This medicine is not recommended if you are taking any other medication belonging to the Selective serotonin reuptake inhibitors (SSRIs) class. This medicine should not take within 14 days of discontinuing treatment with an SSRI medicine. Similarly, an SSRI medicine can be taken seven days after stopping the uptake of this medicine.
Nitrate containing medicines
This medicine is not recommended for patients receiving any other medication containing nitrates due to the increased risk of severe adverse effects.
Strong CYP3A4 inhibitors